Whole-Transcriptome Sequencing Identifies Novel IRF2BP2-CDX1 Fusion Gene Brought about by Translocation t(1;5)(q42;q32) in Mesenchymal Chondrosarcoma

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Nyquist, Kaja B ^a,b,c   Panagopoulos, Ioannis ^a,b   Thorsen, Jim ^a,b   Haugom, Lisbeth ^a,b   Gorunova, Ludmila ^a,b   Bjerkehagen, Bodil ^a   Fosså, Alexander ^a   Guriby, Marianne ^a,b   Nome, Torfinn ^a,b   Lothe, Ragnhild A ^a,b   Skotheim, Rolf I ^a,b   Heim, Sverre ^a,b,c   Micci, Francesca ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; METHOTREXATE; TRANSCRIPTOME;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CHILD; CHONDROSARCOMA; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 1; CYTOGENETICS; DRUG MEGADOSE; EXPRESSED SEQUENCE TAG; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; INTRON; IRF2BP2 CDX1 GENE; KARYOTYPE; ONCOGENE; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; SCHOOL CHILD; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR BIOPSY;

ADULT; BIOPSY; CARRIER PROTEINS; CHILD; CHONDROSARCOMA, MESENCHYMAL; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOMES, ARTIFICIAL, BACTERIAL; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MIDDLE AGED; MODELS, GENETIC; NUCLEAR PROTEINS; TRANSCRIPTOME;

EID: 84869860019     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049705     Document Type: Article

References (36)

1. Fletcher CDM, Unni KK, Mertens F, editors (2002) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARCPress.
2. Mertens F, Antonescu CR, Hohenberger P, Ladanyi M, Modena P, et al. (2009) Translocation-related sarcomas. Semin Oncol 36: 312-323.
3. Mitelman F, Johansson B, Mertens F, (2007) The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7: 233-245.
4. Nakashima Y, Park JH, Sugano O (2002) Mesenchymal chondrosarcoma. In: Fletcher C, Unni K, Mertens F, editors. WHO classification of solide and soft tissue tumors. Lyon: IARCPress.
5. Nakashima Y, Unni KK, Shives TC, Swee RG, Dahlin DC, (1986) Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer 57: 2444-2453.
6. Riedel RF, Larrier N, Dodd L, Kirsch D, Martinez S, et al. (2009) The clinical management of chondrosarcoma. Curr Treat Options Oncol 10: 94-106.
7. Dantonello TM, Int-Veen C, Leuschner I, Schuck A, Furtwaengler R, et al. (2008) Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups. Cancer 112: 2424-2431.
8. Cesari M, Bertoni F, Bacchini P, Mercuri M, Palmerini E, et al. (2007) Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution. Tumori 93: 423-427.
9. Mitelman F, Johansson B, Mertens F, (Eds) (2012) Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. Available: http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed 2012 May.
10. Wang L, Motoi T, Khanin R, Olshen A, Mertens F, et al. (2012) Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 51: 127-139.
11. Abrey LE, Yahalom J, DeAngelis LM, (2000) Treatment for primary CNS lymphoma: the next step. J Clin Oncol 18: 3144-3150.
12. Mandahl N (2001) Methods in solid tumour cytogenetics. In: Rooney DE, editor. Human Cytogenetics: Malignancy and acquired abnormalities. 3 ed. New York: Oxford University Press.
13. Shaffer LG, Slovak ML, Campbell LJ, editors (2009) ISCN 2009: An International System for Human Cytogenetic Nomenclature (2009). Basel: S. Karger.
14. Nyquist KB, Thorsen J, Zeller B, Haaland A, Troen G, et al. (2011) Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12). Cancer Genet 204: 147-152.
15. McPherson A, Hormozdiari F, Zayed A, Giuliany R, Ha G, et al. (2011) deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput Biol 7: e1001138.
16. Kalendar R, Lee D, Schulman AH, (2011) Java web tools for PCR, in silico PCR, and oligonucleotide assembly and analysis. Genomics 98: 137-144.
17. Childs KS, Goodbourn S, (2003) Identification of novel co-repressor molecules for Interferon Regulatory Factor-2. Nucleic Acids Res 31: 3016-3026.
18. Holland PW, Booth HA, Bruford EA, (2007) Classification and nomenclature of all human homeobox genes. BMC Biol 5: 47.
19. Treisman J, Harris E, Wilson D, Desplan C, (1992) The homeodomain: A new face for the helix-turn-helix? BioEssays 14: 145-150.
20. Lohnes D, (2003) The Cdx1 homeodomain protein: an integrator of posterior signaling in the mouse. BioEssays 25: 971-980.
21. Shah N, Sukumar S, (2010) The Hox genes and their roles in oncogenesis. Nat Rev Cancer 10: 361-371.
22. Grier DG, Thompson A, Kwasniewska A, McGonigle GJ, Halliday HL, et al. (2005) The pathophysiology of HOX genes and their role in cancer. J Pathol 205: 154-171.
23. Bonner CA, Loftus SK, Wasmuth JJ, (1995) Isolation, characterization, and precise physical localization of human CDX1, a caudal-type homeobox gene. Genomics 28: 206-211.
24. Silberg DG, Furth EE, Taylor JK, Schuck T, Chiou T, et al. (1997) CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium. Gastroenterology 113: 478-486.
25. Mallo GV, Rechreche H, Frigerio JM, Rocha D, Zweibaum A, et al. (1997) Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int J Cancer 74: 35-44.
26. Kang JM, Lee BH, Kim N, Lee HS, Lee HE, et al. (2011) CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancer. J Korean Med Sci 26: 647-653.
27. Chan CW, Wong NA, Liu Y, Bicknell D, Turley H, et al. (2009) Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1. Proc Natl Acad Sci U S A 106: 1936-1941.
28. Wong NA, Britton MP, Choi GS, Stanton TK, Bicknell DC, et al. (2004) Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines. Proc Natl Acad Sci U S A 101: 574-579.
29. Riedt T, Ebinger M, Salih HR, Tomiuk J, Handgretinger R, et al. (2009) Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia. Blood 113: 4049-4051.
30. Scholl C, Bansal D, Dohner K, Eiwen K, Huntly BJ, et al. (2007) The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis. J Clin Invest 117: 1037-1048.
31. Frohling S, Scholl C, Bansal D, Huntly BJ, (2007) HOX gene regulation in acute myeloid leukemia: CDX marks the spot? Cell Cycle 6: 2241-2245.
32. Chase A, Reiter A, Burci L, Cazzaniga G, Biondi A, et al. (1999) Fusion of ETV6 to the caudal-related homeobox gene CDX2 in acute myeloid leukemia with the t(12;13)(p13;q12). Blood 93: 1025-1031.
33. Koeppel M, van Heeringen SJ, Smeenk L, Navis AC, Janssen-Megens EM, et al. (2009) The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response. Nucleic Acids Res 37: 322-335.
34. Carneiro FR, Ramalho-Oliveira R, Mognol GP, Viola JP, (2011) Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity. Mol Cell Biol 31: 2889-2901.
35. Su A, Wu C, Macleod I (2012) BioGPS. Available: http://biogps.org/#goto=genereport&id=359948. Accessed 2012 May.
36. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101: 6062-6067.